Clinical Trial Update: Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Apatinib plus Capecitabine versus Apatinib alone in patients with advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Capecitabine (capecitabine)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN